New Key Statistics Module, Z-Score and F-Score
NYSE:CRL Key Ratios
Market Cap $ M | 11,797.52 |
Enterprise Value $ M | 14,587.13 |
P/E(ttm) | 24.81 |
PE Ratio without NRI | 20.71 |
Forward PE Ratio | 20.92 |
Price/Book | 3.27 |
Price/Sales | 2.85 |
Price/Free Cash Flow | 32.26 |
Price/Owner Earnings | 26.03 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4,129.00 |
EPS (TTM) $ | 9.23 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | 15.20 |
5-y EBITDA Growth Rate % | 15.20 |
y-y EBITDA Growth Rate % | 4.40 |
EV-to-EBIT | 20.32 |
EV-to-EBITDA | 14.13 |
PEG | 1.36 |
Shares Outstanding M | 51.51 |
Net Margin (%) | 11.49 |
Operating Margin % | 14.95 |
Pre-tax Margin (%) | 14.08 |
Quick Ratio | 1.16 |
Current Ratio | 1.52 |
ROA % (ttm) | 6.10 |
ROE % (ttm) | 14.61 |
ROIC % (ttm) | 7.12 |
Dividend Yield % | -- |
Altman Z-Score | 2.76 |
CRL Number of Guru Trades
CRL Volume of Guru Trades
Gurus Latest Trades with NYSE:CRL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:CRL is held by these investors
Total 3
Charles River Laboratories International Inc Insider Transactions
No Available Data
News about NYSE:CRL
Total 0- 1